关键词：阴道萎缩；激素替代疗法（HRT）；雌激素药膏；治疗；PVA
摘 要：Vaginal atrophy also known as atrophic vaginitis is defined as a decrease in the production of estrogen after menopause, leading to thinning, drying, and reduced elasticity of the vaginal tissues. Up to 40% of post-menopausal women have symptoms of atrophic vaginitis. It typically affects women in the age group of 45-55 years. PVA result in symptoms such as itching, burning, dryness, and dyspareunia. Topical preparations such as hormone replacement therapy (HRT) and estrogen creams are used to treat PVA.
目 录：

PART 01: Executive summary

Highlights

PART 02: Scope of the report

Market overview

Top-vendor offerings

Assumptions

PART 03: Market research methodology

Research methodology

Economic indicators

PART 04: Introduction

Key market highlights

Key buying criteria

PART 05: Overview: Vaginal atrophy

Symptoms

Causes

Pathophysiology

Diagnosis

Treatment

Epidemiology

PART 06: Branded drug profiles

Activella

Enjuvia

Estrace

Femring

Premarin

Osphena

Vagifem

PART 07: Market landscape

Market overview

Market size and forecast

PART 08: Market segmentation by drug class

Topical estrogen

Systemic estrogen

PART 09: Geographical segmentation

Global PVA drugs market by geographical segmentation

2015-2020

PVA drugs market in Americas

PVA drugs market in US

PVA drugs market in EMEA

PVA drugs market in Europe

PVA drugs market in APAC

PVA drugs market in Japan

PART 10: Market drivers

Significant unmet medical needs

Favorable healthcare reforms in US

Increase in awareness of PVA

Cost-effective OTC drugs

PART 11: Impact of drivers

PART 12: Market challenges

Patent expiry of branded products

Low diagnosis rates

Poor patient adherence

Side effects of drugs

PART 13: Impact of drivers and challenges

PART 14: Market trends

Paradigm shift to non-estrogenic therapies

Increased R&D

Patient assistance programs

Strategic alliances

PART 15: Vendor landscape

Competitive scenario

Market share analysis 2015

Pfizer

Allergan

Shionogi

Novo Nordisk

Teva Pharmaceutical

Other prominent vendors

PART 16: Appendix

List of abbreviations

PART 17: Explore Technavio